Universitätsklinikum Heidelberg

Carboplatin/Pegylated Liposomal Doxorubicin/Bevacizumab (CD-Bev) vs. Carboplatin/Gemcitabine/Bevacizumab (CG-BEV) in Patients with Recurrent Ovarian Cancer: a Prospective Randomized Phase iii Engot/GCiG-Intergroup Study (Ago Study Group, Ago-AUSTRiA, ANZGOG,GiNECO, SGCTG) (2020) Hanker L, Harter P, Sehoul L, Rau J, Canzler U, Schmalfeldt B, Thiel F, et al. Conference contribution Phase III PAOLA-1/ENGOT-OV25 Trial: Olaparib Plus Bevacizumab (BEV) As Maintenance Therapy in Patients (PTS) with Newly Diagnosed, Advanced Ovarian Cancer (OC) Treated with Platinum-Based Chemotherapy (PCH) Plus Bev (2020) De Gregorio N, Harter P, Sehouli L, Canzler U, Marme F, Buderath P, Lueck HJ, et al. Conference contribution Serio - Side Effect Registry in Immuno-Oncology (2020) Koutzamanidis R, Mentzer D, Knauss S, Broeckelmann PJ, Hassel JC, Ugurel-Becker S, Pavel ME, et al. Conference contribution Medizinische Betreuung von jungen Frauen mit Ullrich-Turner-Syndrom in Deutschland (2020) Dörr HG, Bettendorf M, Binder G, Braemswig J, Hauffa BP, Holterhus PM, Mohnike K, et al. Journal article Scleroderma renal crisis: Risk factors for an increasingly rare organ complication (2020) Moinzadeh P, Kuhr K, Siegert E, Blank N, Sunderkoetter C, Henes J, Krusche M, et al. Journal article The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements (2020) Hoffmann-Vold AM, Maher TM, Philpot EE, Ashrafzadeh A, Barake R, Barsotti S, Bruni C, et al. Journal article Intraoperative imaging and visualization Intraoperative Bildgebung und Visualisierung (2020) Maier-Hein L, Gockel I, Speidel S, Wendler T, Teber D, Maerz K, Tizabi M, et al. Journal article, Review article S1 guidelines "lumbar puncture and cerebrospinal fluid analysis" (abridged and translated version). (2020) Tumani H, Petereit HF, Gerritzen A, Gross CC, Huss AM, Isenmann S, Jesse S, et al. Journal article Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial. (2020) Zimmer L, Livingstone E, Hassel JC, Fluck M, Eigentler T, Loquai C, Haferkamp S, et al. Journal article AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020. (2020) Ditsch N, Untch M, Kolberg-Liedtke C, Jackisch C, Krug D, Friedrich M, Janni W, et al. Journal article, Review article